Cargando…
Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
The world faces an exceptional new public health concern caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), subsequently termed the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO). Although the clinical symptoms mostly have been characterized, the...
Autores principales: | Romero, Alejandro, Ramos, Eva, López-Muñoz, Francisco, Gil-Martín, Emilio, Escames, Germaine, Reiter, Russel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415199/ https://www.ncbi.nlm.nih.gov/pubmed/32772307 http://dx.doi.org/10.1007/s10571-020-00938-8 |
Ejemplares similares
-
The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
por: Ramos, Eva, et al.
Publicado: (2021) -
Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022) -
Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
por: Egea, Javier, et al.
Publicado: (2022) -
Coronavirus Disease 2019: Latest Data on Neuroinvasive Potential
por: Haddadi, Kaveh, et al.
Publicado: (2020) -
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics
por: Ramos, Eva, et al.
Publicado: (2023)